Resources Kraft, Stephanie, Lisa Buchenauer, and Tobias Polte
What the Findings Mean for Future Treatment in the UK Retatrutide requires phase 3 trial completion, MHRA marketing authorisation, and a NICE health technology appraisal before it could be used in the UK
2018;155:458468.e8
Supplements and age-related eye conditions
Timely use of nutritional therapy with fiber-rich, adequate protein and micronutrient content may help optimize nutritional status, mitigate loss of muscle mass, and improve overall health
Although these findings suggest leptin has detrimental effects, whole-body leptin receptor knockout mice display delayed cellular proliferation and differentiation, elevated MMP-3 levels, and higher apoptosis rates, leading to IVDD (14, 18)